News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
394,920 Results
Type
Article (26507)
Company Profile (66)
Press Release (368345)
Multimedia
Podcasts (35)
Webinars (7)
Section
Business (104588)
Career Advice (477)
Deals (16960)
Drug Delivery (54)
Drug Development (47862)
Employer Resources (49)
FDA (12368)
Job Trends (8505)
News (186773)
Policy (19561)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1762)
Accelerated approval (14)
Adcomms (10)
Allergies (114)
Alliances (26886)
ALS (97)
Alzheimer's disease (981)
Antibody-drug conjugate (ADC) (164)
Approvals (12707)
Artificial intelligence (318)
Autoimmune disease (95)
Automation (8)
Bankruptcy (142)
Best Places to Work (6905)
BIOSECURE Act (5)
Biosimilars (74)
Biotechnology (46)
Bladder cancer (124)
Brain cancer (37)
Breast cancer (422)
Cancer (3103)
Cardiovascular disease (266)
Career advice (432)
Career pathing (16)
CAR-T (135)
CDC (26)
Celiac Disease (2)
Cell therapy (373)
Cervical cancer (26)
Clinical research (43060)
Collaboration (873)
Compensation (275)
Complete response letters (16)
COVID-19 (1570)
CRISPR (37)
C-suite (510)
Cystic fibrosis (59)
Data (4271)
Decentralized trials (2)
Denatured (21)
Depression (93)
Diabetes (318)
Diagnostics (3725)
Digital health (32)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (98)
Drug pricing (93)
Drug shortages (22)
Duchenne muscular dystrophy (127)
Earnings (38742)
Editorial (30)
Employer branding (7)
Employer resources (48)
Events (54323)
Executive appointments (597)
FDA (14672)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (6)
Frontotemporal dementia (10)
Funding (769)
Gene editing (77)
Generative AI (22)
Gene therapy (266)
GLP-1 (548)
Government (3149)
Grass and pollen (4)
Guidances (230)
Healthcare (12256)
HIV (39)
Huntington's disease (20)
IgA nephropathy (50)
Immunology and inflammation (84)
Immuno-oncology (28)
Indications (74)
Infectious disease (1709)
Inflammatory bowel disease (111)
Inflation Reduction Act (7)
Influenza (56)
Intellectual property (120)
Interviews (44)
IPO (7086)
IRA (23)
Job creations (1851)
Job search strategy (394)
JPM (19)
Kidney cancer (11)
Labor market (36)
Layoffs (196)
Leadership (10)
Legal (3655)
Liver cancer (66)
Longevity (7)
Lung cancer (490)
Lymphoma (253)
Machine learning (16)
Management (17)
Manufacturing (292)
MASH (108)
Medical device (13312)
Medtech (13358)
Mergers & acquisitions (10387)
Metabolic disorders (763)
Multiple sclerosis (100)
NASH (11)
Neurodegenerative disease (164)
Neuropsychiatric disorders (42)
Neuroscience (1706)
NextGen: Class of 2026 (3946)
Non-profit (2849)
Now hiring (35)
Obesity (317)
Opinion (98)
Ovarian cancer (120)
Pain (141)
Pancreatic cancer (143)
Parkinson's disease (164)
Partnered (17)
Patents (229)
Patient recruitment (363)
Peanut (43)
People (35742)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12380)
Phase 2 (18633)
Phase 3 (15287)
Pipeline (3155)
Policy (126)
Postmarket research (1671)
Preclinical (3815)
Press Release (19)
Prostate cancer (181)
Psychedelics (26)
Radiopharmaceuticals (178)
Rare diseases (436)
Real estate (2874)
Recruiting (20)
Regulatory (15751)
Reports (18)
Research institute (1662)
Resumes & cover letters (55)
Rett syndrome (16)
RNA editing (5)
RSV (39)
Schizophrenia (115)
Series A (116)
Series B (94)
Service/supplier (2)
Sickle cell disease (46)
Special edition (6)
Spinal muscular atrophy (104)
Sponsored (16)
Startups (2144)
Stomach cancer (11)
Supply chain (60)
Tariffs (26)
The Weekly (14)
Vaccines (515)
Venture capital (32)
Weight loss (212)
Women's health (57)
Worklife (4)
Date
Last 7 days (330)
Last 30 days (1096)
Last 365 days (16142)
2026 (1801)
2025 (16490)
2024 (19890)
2023 (22797)
2022 (30775)
2021 (33084)
2020 (32244)
2019 (28457)
2018 (21850)
2017 (18926)
2016 (18155)
2015 (21252)
2014 (16043)
2013 (13260)
2012 (14372)
2011 (14646)
2010 (13200)
Location
Africa (369)
Alabama (31)
Alaska (2)
Arizona (177)
Arkansas (10)
Asia (25558)
Australia (4038)
California (5626)
Canada (1929)
China (797)
Colorado (287)
Connecticut (294)
Delaware (250)
Europe (50082)
Florida (958)
Georgia (228)
Hawaii (1)
Idaho (35)
Illinois (585)
India (32)
Indiana (381)
Iowa (11)
Japan (322)
Kansas (91)
Kentucky (19)
Louisiana (18)
Maine (28)
Maryland (899)
Massachusetts (3788)
Michigan (155)
Minnesota (448)
Mississippi (5)
Missouri (80)
Montana (19)
Nebraska (21)
Nevada (65)
New Hampshire (73)
New Jersey (1941)
New Mexico (10)
New York (1583)
North Carolina (821)
North Dakota (4)
Northern California (2677)
Ohio (215)
Oklahoma (8)
Oregon (28)
Pennsylvania (1362)
Puerto Rico (12)
Rhode Island (35)
South America (524)
South Carolina (60)
Southern California (2257)
Tennessee (126)
Texas (1027)
United States (21850)
Utah (194)
Virginia (143)
Washington D.C. (52)
Washington State (388)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
394,920 Results for "arsenal medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Arsenal Medical Announces Treatment of First Patient with NeoCast™
Arsenal Medical today announced enrollment of the first patient with the company’s investigational NeoCast™ embolic biomaterial.
July 26, 2023
·
2 min read
Biotech Bay
Arsenal Biosciences Announces Presentation of Four Abstracts at AACR Annual Meeting Highlighting New CAR T-Focused Research
Arsenal Biosciences, Inc. (ArsenalBio), a clinical-stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid tumors, today announced the presentation of four abstracts at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA., May 5-10, 2024.
April 5, 2024
·
5 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
·
2 min read
Biotech Bay
Arsenal Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Arsenal Biosciences, Inc. (ArsenalBio) today announced that Ken Drazan, MD, the company’s Chairman and Chief Executive Officer, will present a corporate update at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 9:30 a.m. PT.
January 2, 2024
·
1 min read
Drug Development
Arsenal Biosciences Announces First Patient Dosed in Phase 1/2 Clinical Trial of AB-2100 in Development as a Treatment for Clear-cell Renal Cell Carcinoma
Arsenal Biosciences, Inc. today announced that the first patient has been dosed with AB-2100 in a multi-center, open-label Phase 1/2 clinical trial for patients with clear-cell renal cell carcinoma (ccRCC).
April 30, 2024
·
3 min read
Bio NC
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
Fortrea, a leading global contract research organization, announced it has signed a definitive agreement to divest assets relating to its Enabling Services segment, namely its Endpoint Clinical and Fortrea Patient Access businesses, to Arsenal Capital Partners, a leading private equity firm specializing in building market-leading, technology-rich healthcare companies.
March 11, 2024
·
8 min read
Press Releases
Nate Hardy to Join Arsenal Biosciences, Inc. as Chief Financial Officer
September 16, 2024
·
2 min read
Drug pricing
Trump Asks Big Pharmas To Move on Most Favored Nation Drug Pricing—Or Else
In 17 identical letters posted to his Truth Social account, the president said companies must lower their prices or the government ‘will deploy every tool in our arsenal to protect American families from continued drug pricing practices.’
July 31, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Intricon becomes Forj Medical and Announces Opening Plans for its Advanced Manufacturing Facility in Costa Rica
Intricon completes construction of its Evolution Free Zone location, combines with Minnetronix Medical, and will fly the Forj Medical flag at its new site; equipment and workforce move into place for the grand opening
December 9, 2025
·
1 min read
Press Releases
Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
February 12, 2026
·
5 min read
1 of 39,492
Next